VOTUBIA 3 mg رومانيا - الرومانية - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

votubia 3 mg

novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 3mg - inhibitori de protein-kinaza inhibitor selectiv al mtor

VOTUBIA 5 mg رومانيا - الرومانية - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

votubia 5 mg

novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 5mg - inhibitori de protein-kinaza inhibitor selectiv al mtor

Kisplyx الاتحاد الأوروبي - الرومانية - EMA (European Medicines Agency)

kisplyx

eisai gmbh - lenvatinib mesilate - carcinomul, celula renală - agenți antineoplazici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.

Funzol capsule 150 mg مولدافيا - الرومانية - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

funzol capsule 150 mg

bosnalijek, pharmaceutical and chemical industry jsc - fluconazolum - capsule - 150 mg